Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention
1 other identifier
observational
402
1 country
1
Brief Summary
Abdominal distention represents a prevalent clinical manifestation characterized by an unclear etiology and pathogenesis. This symptomatology is frequently observed in various conditions, including small intestinal bacterial overgrowth (SIBO) and abnormal orocecal transit time (OCTT). The utilization of the breath test as a non-invasive diagnostic approach has become widespread in recent years for identifying SIBO and abnormalities in OCTT. In this study, the prevalence of SIBO and OCTT irregularities in individuals presenting with abdominal distention was ascertained through the implementation of the breath test. Furthermore, the correlation between abdominal distention and SIBO/OCTT was analysed to enhance the elucidation of the underlying etiology of abdominal distention. These findings aim to offer valuable insights for refining clinical comprehension and strategies related to the diagnosis and treatment of abdominal distention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 29, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedDecember 12, 2024
December 1, 2024
1.4 years
February 5, 2024
December 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive rate of SIBO in patients with abdominal distension
Detect the positive rate of SIBO in patients with abdominal distension by breath test
2024-03-01 to 2025-08-01
Secondary Outcomes (3)
Positive rate of abnormal OCTT in patients with abdominal distension
2024-03-01 to 2025-08-01
Correlation between clinical features of patients with abdominal distension and SIBO
2024-03-01 to 2025-08-01
Correlation between clinical features of patients with abdominal distension and OCTT
2024-03-01 to 2025-08-01
Interventions
The concentration of methane and hydrogen in the exhaled gas of patients with Abdominal distention is measured by a breath test to determine the presence of SIBO and abnormal OCTT.
Eligibility Criteria
Abdominal distension patients in the outpatient department at Qilu Hospital of Shandong University.
You may qualify if:
- Patients aged 18 to 70 years.
- Patients presenting with the primary complaint of abdominal bloating and/or abdominal distension, or those exhibiting abdominal distension with prominence over other symptoms.
You may not qualify if:
- Patients who are pregnant or lactating.
- Patients have history of gastrointestinal malignancy or gastrointestinal surgery.
- Patients manifesting food intolerance or presenting with a confirmed diagnosis or suspicion of lactose intolerance.
- Patients with urinary system (chronic kidney disease, etc.), immune system (scleroderma, etc.), nervous system (Parkinson's disease, etc.), mental system (depression, etc.), or other diseases outside the digestive system.
- Patients who used antibiotics or microecological agents or underwent endoscopic examination within two weeks.
- Patients with a medication history encompassing motility enhancers, secretory enhancers, antifoaming agents, spasmolytics, opioids, and antidepressants within the past week.
- Patients who are unwilling or incapable to provide informed consents.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shandong Universitylead
- Qilu Hospital of Shandong University (Qingdao)collaborator
- Jinan Central Hospitalcollaborator
- Zaozhuang Municipal Hospitalcollaborator
- Weihai Municipal Hospitalcollaborator
- Central Hospital of Zibocollaborator
- Weifang People's Hospitalcollaborator
- Binzhou Medical Universitycollaborator
- Qihe Xian Renmin Hospitalcollaborator
- Dezhou Hospital Qilu Hospital of Shandong Universitycollaborator
Study Sites (1)
Gastroenterology Department of Qilu Hospital
Jinan, Shandong, 250012, China
Biospecimen
The exhaled air of the patient after taking the substrate.
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Feixue Chen, MD
Qilu Hospital of Shandong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director of gastroenterology department of Qilu hospital
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 29, 2024
Study Start
March 1, 2024
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
December 12, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share